- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Scibase Holding AB: Interim report | 64 | GlobeNewswire (Europe) | January 1 - March 31, 2026
The first quarter in figures
Net sales were TSEK 14,278 (8,856), +61%, cleared for currency effects +80%.
The loss after tax was TSEK 24,490 (20,682).
The loss per share... ► Artikel lesen | |
| 27.04. | SciBase publishes the Annual report for 2025 | 231 | PR Newswire | STOCKHOLM, April 27, 2026 /PRNewswire/ -- SciBase hereby announces that the Annual report for 2025 is available at the Company's website www.scibase.com.
A pdf-version of the annual... ► Artikel lesen | |
| 14.04. | Notice to attend the annual general meeting in Scibase Holding AB (publ) | 3 | Cision News | ||
| 07.04. | SciBase reaches milestone with over 400,000 tests sold with Nevisense | 265 | PR Newswire | STOCKHOLM, April 7, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced a significant... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 13.03. | Scibase Holding AB: Interim report | 216 | GlobeNewswire (Europe) | January 1 - December 31, 2025
The fourth quarter in figures
Net sales were TSEK 12,475 (8,598), +45%, cleared for currency effects +57%.
The loss after tax was TSEK 25,300 (21,677).
The loss per... ► Artikel lesen | |
| 10.03. | SciBase: New Study Positions Nevisense's EIS as a valuable and sensitive tool for assessing skin barrier impairment | 424 | PR Newswire | STOCKHOLM, March 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, is pleased to announce the publication... ► Artikel lesen | |
| 05.03. | SCIBASE: New Publication: US clinicians' real-world Nevisense experience improves melanoma detection | 3 | Cision News | ||
| 02.03. | SciBase receives approval by FDA for extended labelling in the US | 360 | PR Newswire | STOCKHOLM, March 2, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received... ► Artikel lesen | |
| 02.03. | Scibase Holding AB: SciBase receives approval by FDA for extended labelling in the US | 312 | GlobeNewswire (Europe) | STOCKHOLM, Sweden - March 2, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, today announced that it has received approval... ► Artikel lesen | |
| 19.02. | SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma | 335 | PR Newswire | STOCKHOLM, Feb. 19, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that Nevisense... ► Artikel lesen | |
| 17.02. | SCIBASE: A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | 2 | Cision News | ||
| 17.02. | Scibase Holding AB: A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | 650 | GlobeNewswire (Europe) | STOCKHOLM, Sweden - February 17, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that results from a new study will... ► Artikel lesen | |
| 06.02. | SciBase: Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue | 343 | PR Newswire | STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April... ► Artikel lesen | |
| 27.01. | SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 386 | PR Newswire | STOCKHOLM, Jan. 27, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on... ► Artikel lesen | |
| 27.01. | Scibase Holding AB: SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 191 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on 29 December 2025 (the "Rights Issue"). The Rights Issue... ► Artikel lesen | |
| 26.01. | SciBase: Change of date for publication of the year-end report for the financial year 2025 | 320 | PR Newswire | STOCKHOLM, Jan. 26, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has resolved to postpone the publication of the year-end report for... ► Artikel lesen | |
| 22.01. | Increased commitment in SciBase rights issue | 292 | PR Newswire | STOCKHOLM, Jan. 22, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announces it has been informed... ► Artikel lesen | |
| 09.01. | SciBase publishes information document regarding rights issue | 470 | PR Newswire | STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") publishes information documents in connection with the rights issue... ► Artikel lesen | |
| 09.01. | SciBase announces outcome of the offer to repurchase outstanding warrants of series TO 2 | 393 | PR Newswire | STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the outcome of the repurchase offer for all warrants of series TO 2 resolved... ► Artikel lesen | |
| 06.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.01.2026 | 588 | Xetra Newsboard | Das Instrument NW1 SE0017131865 WINDON ENERGY GROUP AB EQUITY wird cum Kapitalmassnahme gehandelt am 06.01.2026 und ex Kapitalmassnahme am 07.01.2026 The instrument NW1 SE0017131865 WINDON ENERGY GROUP... ► Artikel lesen |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 108,50 | -0,18 % | Roku to Stream Inaugural Enhanced Games in North America | ||
| SERNOVA BIOTHERAPEUTICS | 0,094 | -3,88 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 45,925 | -0,42 % | BOSTON SCIENTIFIC CORP - S-8, Securities to be offered to employees in employee benefit plans | ||
| PAUL HARTMANN | 207,00 | +0,49 % | Dividendenbekanntmachungen (30.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| SYSMEX | 6,980 | -0,82 % | neotares realisiert neuen Unternehmenssitz in Hamburg für Sysmex | ||
| EMBECTA | 2,902 | +0,35 % | Embecta stock rating held at Neutral by BTIG after investor meetings | ||
| ADDLIFE | 13,360 | +0,75 % | Dividendenbekanntmachungen (07.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCELLERON INDUSTRIES AG ADR US00449R1095 1,8766 USD 1,5973 EUR ACRINOVA AB SE0015660014 3,75 SEK 0,3453 EUR ACRINOVA AB B SE0015660030 3... ► Artikel lesen | |
| ENOVIS | 21,000 | -5,41 % | Enovis Corporation: Enovis Announces First Quarter 2026 Results | First-quarter sales growth of 5% on a reported basisFirst-quarter Reconstructive sales grew 11% on a reported basisReiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash... ► Artikel lesen | |
| PULMONX | 1,100 | 0,00 % | Pulmonx Corporation: Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results | REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| SI-BONE | 11,400 | -4,20 % | SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance | First Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth... ► Artikel lesen | |
| LIFECARE ASA | 0,039 | +19,63 % | Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation | ||
| PEIJIA MEDICAL | 0,635 | 0,00 % | Peijia Medical Announces 2025 Annual Results | SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and... ► Artikel lesen | |
| KOOTH | 1,570 | +1,95 % | Kooth PLC - 2025 Impact Report Shows Soluna's Continued Growth | ||
| BACTIGUARD | 1,530 | +0,66 % | Bactiguard Holding AB: Bactiguard and BD strengthen global partnership expanding access to Foley catheters designed to reduce infection risk for patients worldwide | Bactiguard Holding AB (publ) today announces an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company), a leading global medical technology company, through... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,19 % bei einem Aktienkurs von 0,017 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.